Prof.Dr. Gül Alço

Hakkında

Gül Alço, Radyasyon Onkoloji alanında Medipol Acıbadem Bölge Hastanesi doktor kadrosunda yer almaktadır.

Eğitim

• 2003
• Kadir Has Üniversitesi Tıp Fakültesi, Radyasyon Onkolojisi
• 1995
• İstanbul Üniversitesi, Tıp Fakültesi

Bilimsel yayınlar

• 1. Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)
• 1.1. S. İğdem, T. Ercan, G. Alço, F. Zengin, R. Özgüleş, G. Geceer, S. Okkan, A. Öber, S. Turkan. Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignancies. Eur J Gynaec Oncol. 2009; 5: 547-551. [29 ATIF]
• 1.2. S. İğdem, H. Akpınar, G. Alço, F. Ağaçayak, S. Turkan, S. Okkan. Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity. Br J Radiol. 2009; 82: 941-945. [60 ATIF]
• 1.3. S. İğdem, U. Abacıoğlu, İ. Çetin, G. Alço, Z. Akgün, M. Şengöz, N. Bekiroğlu, S. Turkan, S. Okkan. Impact of Percent Positive Random Biopsies on Biochemical Outcome in Prostate Cancer Patients Treated with External Beam Radiotherapy With or Without Androgen Deprivation. JBUON 2009; 14: 629-634. [3 ATIF]
• 1.4. G. Alço, Ş. İğdem, M. Dinçer, C. Tecimer, R. Şentürk, M. Vural, S. Okkan. Gemcitabine induced radiation recall myositis: Report of two cases and review of the literature. UHOD 2009;19:249-253. [5 ATIF]
• 1.5. G. Alço, Ş. İğdem, T. Ercan, M. Dinçer, R. Şentürk, S. Atilla, F. Zengin, S. Okkan. Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy. Br J Radiol. 2010; 83: 1072-1076. [71 ATIF]
• 1.6. Ş. İğdem, G. Alço, T. Ercan, B. Ünalan, B. Kara, G. Geceer, C. Akman, F.O. Zengin, S. Atilla, S. Okkan. The application of positron emission tomography/computed tomography in radiation treatment planning: Effect on gross target volume definition and treatment management. Clinical Oncology 2010; 22:173-178. [19 ATIF]
• 1.7. T. Ercan, Ş. İğdem, G. Alço, F. Zengin, S. Atilla, M. Dinçer, S. Okkan. Dosimetric comparison of field-in-field intensity modulated radiotherapy technique with conformal radiotherapy techniques in breast cancer. Jpn J Radiol 2010; 28: 283-289. [59 ATIF]
• 1.8. Ş. İğdem, G. Alço, T. Ercan, M. Barlan, K. Ganiyusufoğlu, B. Ünalan, S. Turkan, S. Okkan. Insufficiency fractures after pelvic radiotherapy in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2010; 77: 818-823. [94 ATIF]
• 1.9. G. Alco, M. Dincer. Are the standard tangential breast irradiation fields used in the ACOSOG Z0011 trial really covering the entire axilla? Ann Surg. 2013; 257 (1):e1 [12 ATIF]
• 1.10. G. Alco, S. Igdem, M. Dincer, V. Ozmen, S. Saglam, D. Selamoglu, Z. Erdogan, C. Ordu, K.N. Pilanci, A. Bozdogan, S. Yenice, C. Tecimer, G. Demir, G. Koksal, S. Okkan. Vitamin D levels in patients with breast cancer: Importance of dressing style. Asian Pac J Cancer Prev. 2014; 15(3): 1357-62. [35 ATIF]
• 1.11. OP. Erpolat, G. Alco, HB. Caglar, S. Igdem, A. Saran, N. Dagoglu, I. Aslay, Z. Ozsaran, S. Demirci, E. Keven, Y. Guney, M. Akmansu, D. Kilic, E. Bayman, D. Etiz, NM. Mandel. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: A national multi-center study. Eur J Gynaecol Oncol. 2014; 35(1):62-6. [48 ATIF]
• 1.12. F Agacayak, A Ozturk, A Bozdogan, D Selamoglu, G Alco, C Ordu, KN Pilanci, R Killi, V Ozmen. Stereotactic vacuum-assisted core biopsy results for non-palpable breast lesions. Asian Pac J Cancer Prev. 2014;15(13):5171-4. [14 ATIF]
• 1.13. G. Alco, A. Bozdogan, D. Selamoglu, K.N. Pilancı, Ç. Ordu, S.Tuzlali, S. Okkan, M. Dincer, S. Igdem, G. Demir, V. Ozmen. Clinical and histopathological factors related to Ki-67 expression in breast cancer patients. Oncol Lett. 2015 Mar;9(3):1046-1054. [49 ATIF]
• 1.14. ZE Iyigun, D Selamoglu, G. Alco, KN Pilancı, C Ordu, F Agacayak, F Elbüken, A Bozdogan, S Ilgun, F Guler Uysal, V Ozmen. Bioelectrical impedance for detecting and monitoring lymphedema in patients with breast cancer. Preliminary results of the florence nightingale breast study group. Lymphat Res Biol. 2015 Mar;13(1):40-5. [40 ATIF]
• 1.15. KN Pilanci, G Alco, C Ordu, D Sarsenov, F Celebi, Z Erdogan, F Agacayak, S Ilgun, C Tecimer, G Demir, Y Eralp, S Okkan, V Ozmen. Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment? Medicine 2015 May;94(18):e671. [22 ATIF]
• 1.16. F Çelebi, KN Pilancı, C Ordu, F Ağacayak, G Alco, S İlgün, D Sarsenov, Z Erdoğan, V Özmen. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer. Diagn Interv Radiol. 2015 Nov-Dec;21(6):448-53. [90 ATIF]
• 1.17. T. Ercan, S İğdem, G Alco. The effect of bladder contrast on dose calculation in volumetric modulated arc therapy planning in patients treated for postoperative prostate cancer. Jpn J Radiol. 2016 May;34(5):376-382. [4 ATIF]
• 1.18. AS Ilgun, D Sarsenov, Z Erdogan, Ç Ordu, F Celebi, KN Pilanci, A Ozturk, D Selamoglu, G Alco, F Aktepe, Y Eralp, S Tuzlali, V Ozmen. Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients. JBUON 2016; 21(6): 1425-1432 [19 ATIF]
• 1.19. ZE Iyigun, T Duymaz, AS Ilgun, G Alco, C Ordu, D Sarsenov, AE Aydin, FE Celebi, F Izci, Y Eralp, V Ozmen. Preoperative lymphedema related risk factors in early stage breast cancer. Lymphat Res Biol. 2018 Feb;16(1):28-35. [35 ATIF]
• 1.20. ZE Iyigun, F Agacayak, AS Ilgun, FE Celebi, C Ordu, G Alco, A Ozturk, T Duymaz, F Aktepe, V Ozmen, The role of eleastography in diagnosis and staging of breast cancer related lymphedema. Lymphat Res Biol. 2018 [23 ATIF]
• 1.21. NK Yıldırım, M Özkan, AS İlgün, D Sarsenov, G Alço, F Aktepe, N Kalyoncu, F İzci, D Selamoğlu, Ç Ordu, KN Pilancı, ZE İyigün, Y Eralp, V Özmen. Possible role of stress, coping strategies, and lifestyle in the development of breast cancer. Int J Psychiatry Med. 2018 May; 53 (3) : 207-220. [16 ATIF]
• 1.22. A Ozturk, G Alco, D Sarsenov, S Ilgun, C Ordu, U Koksal, KN Pilanci, Z Erdogan, F Izci, F Elbuken, F Agacayak, F Aktepe, V Ozmen, Synchronous and metachronous bilateral breast cancer: A long-term experience, JBUON 2018; 23(6): 1591-1600 [28 ATIF]
• 1.23. F Çelebi, F Agacayak, A Ozturk, S Ilgun, M Ucuncu, ZE Iyigun, Ç Ordu, KN Pilanci, G Alco, S Gultekin, E Cindil, G Soybir, F Aktepe, V Özmen. Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer. Eur Radiol 30, 2049–2057 (2020). [26 ATIF]
• 1.24. V Ozmen, S Ilgun, BC Ozden, A Ozturk, F Aktepe, F Agacayak, F Elbuken, G Alco, C Ordu, ZE Iyigun, E Hocaoglu, K Pilancı, G Soybir, T Ozmen. Comparison of breast cancer patients wo underwent partial mastectomy (PM) with mini latissimus dorsi flap (MLDF) and subcutaneous mastectomy with implant (M+I) regarding quality of life (QOL), cosmetic outcome and survival rates. World J Surg Onc 18, 87 (2020). [11 ATIF]
• 1.25. A. Ozturk A, S. Ilgun S, M Ucuncu, F Gachayev, C Ordu, G Alco, F Elbuken, Z Erdogan, T Duymaz, F Aktepe, G Soybir, V Ozmen. The effect of multifocal and multicentric tumours on local recurrence and survival outcomes in breast cancer. JBUON, 2021 Jan-Feb; 26(1):196-203. [5 ATIF]
• 1.26. KN Pilancı, Ç. Ünal, Ç. Ordu, E. Gökmen, M. Özdoğan, N. Güler, C. Uras, O. Demircan, A. Işıkdoğan, H. Kara, AB Oz, G. Alço, P. Saip, Y. Eralp, V. Özmen. Correlation between clinicopathologic factors and recurrence score according to TAILOR x risk category in patients with hormone receptor positive early stage breast cancer. JBUON, 2021
• 1.27. Akyuz Cim, E. F., Torlak, E., Unveren, G., Soybir, G. R. ., Ozmen, V., ErdoGan Iyigun, Z., Kayan Tapan, T., Yesilova, A., Alco, G., Yilmaz, E., Eyrenci, A., Elbuken, F., Ilgun, A. S., Duymaz, T., Ordu, C., & Pilanci, K. N. (2022). Effect of Fear of Covid-19 Infection on Functionality in Breast Cancer Patients in the Pandemic. Iranian Red Crescent Medical Journal, 24(2).
• 1.28. Ilgun, A. S., Alco, G., Ozturk, A., Celebi, F., Erdogan, Z., Ordu, C., Ozmen, Aktepe F, Soybir G, Özmen V. The effect of boost radiotherapy on local control in ductal carcinoma in-situ of the breast: Retrospective single-center experience with literature review. JBUON 2021; 26(6): 2298-2305.
• 1.29. Ozmen V, Ordu C, Ilgun AS, Unal C, Soybir G, Erdogan Z, Kayan Tapan T, Aktepe F, Alco G, Duymaz T, Ozmen T. The effects of vitamin D replacement on pathological complete response (pCR) in breast cancer patients receiving neoadjuvant systemic chemotherapy (NAC). Breast J. 2021 Dec;27(12):902-905.
• 1.30. Ozmen V, Caglayan AO, Yararbas K, Ordu C, Aktepe F, Ozmen T, Ilgun AS, Soybir G, Alco G, Tsaousis GN, et al: Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer. Oncol Lett 23: 118, 2022 [1 ATIF]
• 1.31. G. Alço, T. Ercan, Ş. İğdem, M. Barlan, M. Dinçer, S. Okkan. Deep inspiration breath hold in left sided tangential breast radiotherapy: Degree of lung inflation needed to compansate for cardiac motion. Int. J. Radiat. Res. April 2022; 20(2): 329-334
• 1.32. AS Ilgun, D Sarsenov, G Alço, A Ozturk, F Agacayak, F Elbuken, Z Erdogan,KN Pilanci, C Ordu, F Aktepe, G Soybir, V Ozmen. Long-term survival effects of preoperative breast MRI in patients with breast-conserving surgery. Acta Clin Croat 2022; 61:30-37
• 1.33. Ahmet Serkan Ilgun, Fatma Aktepe, Onur Gonullu, Nilgun Kapucuoglu, Kanay Yararbas, Gul Alco, Alper Ozturk, Filiz Elbuken Celebi, Zeynep Erdogan, Cetin Ordu, Caglar Unal, Tomris Duymaz, Gursel Soybir, Ekrem Yavuz, Sitki Tuzlali, and Vahit Ozmen. The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer. Future Oncology 2022 18:29, 3289-3298
• 1.34. Ünal C¸ Özmen T, Ordu C¸ , Pilanci KN, Ilgün AS, Gökmen E, Almuradova E, Özdogan M, Güler N, Uras C, Kara H, Demircan O, Is¸ık S, Alc¸o G, Saip P, Aydın E, Duymaz T, Celebi F, Yararbas¸ K, Soybir G and Ozmen V (2023) Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey. Front. Oncol. 13:1151733 [4 ATIF]
• 1.35. Ünal, Ç.; Ordu, Ç.; Özmen, T.; ˙Ilgun, A.S.; Çelebi, F.; Baysal, B.;Özkurt, E.; Duymaz, T.; Erdogan Iyigün, Z.; Kurt S, Öztürk MA, Pilancı KN, Alço G, Yararbas K, Kayan Tapan T, Guven DC, Soybir G, Ozmen V. Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study. Curr. Oncol. 2023, 30, 9217–9229.
• 1.36 Ç. Ünal, T. Özmen, AS İlgün, Ç Ordu, E Özkurt, N Ak, G Alço, ZE İyigün, S Kurt, T Duymaz, MA Öztürk, FE Çelebi, K Yararbaş, G Soybir, F Aktepe & V Özmen. MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification, Breast Cancer: Targets and Therapy, 2023, 659-669. [1 ATIF]
• 2. Uluslararası diğer hakemli dergilerde yayınlanan makaleler
• 2.1. G Alço, S Igdem, S Okkan, M Dincer, D Sarsenov, AS Ilgun, F Agacayak, F Elbüken, T Ercan, D Selamoglu, V Ozmen. Replacement of the tumor bed following oncoplastic breast‑conserving surgery with immediate latissimus dorsi mini‑flap. Mol Clin Oncol 5: 365-371, 2016 [27 ATIF]
• 2.2. C Ordu, KN Pilancı, N Avci, I Yıldız, G Alco, UI Koksal, F Celebi, C Tecimer, OG Demir. Prognostic Relevance of Sunitinib Toxicities and Comparison of Continuous vs Intermittent Sunitinib Dosing Schedule in Metastatic Renal Cell Cancer Patients. Contemporary Oncology, 2016, 20(2), 147-152. [1 ATIF]

Çalışma yerleri 1